The Cyclical Nature of US Health Care Reform

The current impasse is particularly frustrating considering that nearly two-thirds of Americans believe the federal government has a responsibility to ensure health coverage for all citizens, according to recent polling data. Gallup consistently shows strong public support for government intervention in healthcare affordability.

Looking back, a clear pattern emerges. Public support for government-led health care solutions tends to peak after periods of significant affordability challenges. This pattern, described by historian Paul Starr as the “remedy and reaction” cycle, plays out as follows:

1. A problem – in this case, unaffordable health care – becomes politically unavoidable.
2. Lawmakers attempt to address the issue with an imperfect solution.
3. Public backlash ensues, often fueled by targeted opposition campaigns.
4. Lawmakers become hesitant to pursue further significant reforms until public frustration reaches a boiling point once more.

For the past sixteen years, the United States has largely been in a “reaction” phase following the passage of the ACA. The ACA aimed to reduce the number of uninsured, particularly among low-income individuals and the working class. While initially met with resistance, the lingering effects of that opposition have made Democrats cautious about proposing sweeping changes in recent years. However, the tide may be turning.

Why Now Might Be Different: A Convergence of Factors

Successful health care reform requires a critical mass of political support, well-developed policy proposals, and a degree of buy-in from key stakeholders in the health care industry. The ACA benefited from Barack Obama’s strong electoral mandate, decades of policy groundwork, and a willingness from hospitals and pharmaceutical companies to avoid a major fight.

These three elements are beginning to align once again. The recent expiration of ACA subsidies and Republican-led Medicaid cuts are likely to intensify public anger and demand for change. Furthermore, the growing trend of direct-to-consumer health care, exemplified by cash purchases of medications like Ozempic, is exacerbating inequities and straining household budgets.

Behind the scenes, policymakers are actively exploring potential solutions. Democrats engaged in a thorough debate during the 2020 presidential primary regarding various reform options, including Medicare for All, a public option, and targeted improvements to private insurance. State-level initiatives, such as public insurance options in Washington and other states, are providing valuable insights that could inform a national plan, mirroring how Massachusetts’s earlier reforms influenced the ACA.

A bipartisan group of lawmakers is currently working on reforms for pharmacy benefit managers, and even the Trump administration has taken steps to lower drug prices – including exploring alignment with international pricing standards, as reported by Jones Day.

Perhaps most significantly, some traditionally resistant industry groups are showing signs of flexibility. The American Medical Association, historically opposed to single-payer systems, has begun softening its stance and has advocated for restoring ACA subsidies and building upon the existing law. Furthermore, as I have reported, some employers are re-evaluating the long-term viability of employer-sponsored insurance due to rising costs, a shift that could open up new possibilities for reform. Legal Clarity provides further insight into this trend.

What does this mean for the future of health care in America? The political landscape will be crucial, with Democrats more likely to champion significant reform. However, even within that context, the stars appear to be aligning: President Trump’s current low approval ratings, as noted by Nate Silver, make a Democratic Senate victory increasingly plausible. A Democratic sweep in 2028 could then create the window of opportunity needed for substantial change. One thing is certain: health care will remain a top priority for voters.

What role should the government play in ensuring affordable health care? And how can we overcome the deep-seated political divisions that have stymied progress for so long?

Frequently Asked Questions About Health Care Reform

1. What is the Affordable Care Act (ACA)? The ACA, also known as Obamacare, is a comprehensive health care reform law enacted in 2010 aimed at increasing health insurance coverage and affordability.
2. Why did the ACA subsidies expire? Congress failed to reach a bipartisan agreement to extend the enhanced subsidies that lowered health insurance premiums for millions of Americans.
3. What is the “remedy and reaction” cycle in health care? This cycle describes the pattern of public support for reform following affordability crises, followed by backlash and political paralysis.
4. Are there any states leading the way in health care innovation? States like Washington are experimenting with public insurance options that could serve as models for national reform.
5. What role are pharmaceutical companies playing in the debate? Some pharmaceutical companies are facing pressure to lower drug prices, and there are signs of a willingness to consider reforms.
6. Could employer-sponsored health insurance disappear? Some companies are considering alternatives to employer-sponsored insurance due to rising costs, which could reshape the health care landscape.